GlobeNewswire Inc.T3·5mo ago
RPID Rapid Micro Biosystems, Inc. Class A Common Stock
XNASStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
RPID
—
—
Key stats
Related
About
- Industry (SIC)
- LABORATORY ANALYTICAL INSTRUMENTS (3826) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 171
- List Date
- 2021-07-15
- CIK
- 0001380106
- Next Earnings
- 2026-11-06
- EPS Forecast
- ($0.20) (2 est.)
- Headquarters
- Lexington, MA
- Homepage
- https://www.rapidmicrobio.com
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devi…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -- | -34.16% | 22.95% | 5.30% | 82.08% | 41.08% | 23.45% |
| Feb | -- | -5.67% | -26.21% | 13.41% | 39.27% | 3.34% | 4.83% |
| Mar | -- | 0.00% | 21.30% | -1.02% | 2.13% | -48.41% | -5.20% |
| Apr | -- | -12.59% | -27.37% | 2.50% | -11.11% | 11.11% | -7.49% |
| May | -- | -10.54% | 10.53% | -13.99% | 48.00% | -20.55% | 2.69% |
| Jun | -- | -8.70% | -0.99% | -18.49% | 0.00% | -12.18% | -8.07% |
| Jul | 3.69% | 13.97% | 1.16% | -2.81% | -4.58% | 24.20% | 5.94% |
| Aug | -19.75% | -24.32% | -0.52% | 25.35% | -27.19% | -28.30% | -12.46% |
| Sep | -3.55% | -2.71% | 12.50% | 6.91% | 40.93% | -31.33% | 3.79% |
| Oct | 10.63% | -14.37% | -5.50% | 24.12% | -13.58% | -14.77%* | -2.24% |
| Nov | -42.24% | -30.51% | 17.00% | -5.00% | 52.36% | -- | -1.68% |
| Dec | -13.28% | -30.25% | -33.93% | -10.00% | -29.61% | -- | -23.41% |
| Total | -55.53% | -84.56% | -27.66% | 17.40% | 209.18% | -69.61% | -1.79% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $0.87
SMA 50: $1.16
SMA 200: $2.29
Current: $0.79
EMA 12: $0.83
EMA 26: $0.94
MACD: -0.1112 | Signal: 0.0129
BEARISH
ADX (14): 31.69
TREND
+DI: 13.62
−DI: 22.39
Momentum Oscillators
RSI (14): 28.76
OVERSOLD
Stoch %K: 9.84
Stoch %D: 10.08
Williams %R: -89.33
Volume & Volatility
BB Upper: $1.04
BB Lower: $0.70
NEUTRAL
OBV: -13,122,600
Vol SMA 20: 204,818
Vol ROC: -65.29%
ATR: $0.07
True Range: $0.04
HV 20: 72.8%
HV 30: 61.7%
HV 60: 66.3%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis
Here is a comprehensive stock analysis report based on the provided data:
Executive Summary
BULLISH/BEARISH: BULLISH (confidence level 8/10)
Key drivers: Positive news sentiment, technical signals indicating oversold conditions, and strong momentum.
Primary risks: High volatility, potential for mean reversion, and lack of earnings guidance.
Investment thesis: RPID is poised to rebound from recent declines due to improving fundamentals, positive news flow, and oversold technical conditions. This analysis highlights the potential for a near-term rally, but also notes the high risk associated with this stock's volatile nature.
Recent news sentiment impact: The positive news headlines have contributed to the bullish thesis, as they highlight RPID's growth prospects and strengthen investor confidence.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): Bearish, Medium-term (1-3 months): Neutral, Long-term (3-12 months): Bullish
Support/Resistance Levels: Key levels to watch: SMA 20 ($2.06), SMA 50 ($1.91), and the recent low of $1.71.
Momentum Signals:
- RSI interpretation: Oversold conditions (<30) indicate a potential buy signal.
- MACD signal: Bullish momentum, as the MACD histogram has crossed above the zero line.
- Bollinger Bands position: Price is touching the lower band, indicating oversold conditions.
Volume Analysis: Volume trends suggest institutional interest and buying pressure at current levels.
News & Sentiment Analysis
Recent Headlines Summary: Positive news flow from recent announcements, including the underwritten offering, conference presentations, and management appointments. This has contributed to a positive sentiment around RPID.
Sentiment Assessment: Aggregate sentiment is POSITIVE (4/5).
Catalyst Identification: Upcoming events include earnings releases and potential catalysts like FDA approvals or product launches.
Market Narrative: The news aligns with the technical signals, indicating oversold conditions and potential for a near-term rally. However, there are risks associated with this stock's volatile nature.
Risk & Volatility Assessment
Beta Interpretation: High risk due to beta >1.5 (vs SPY).
Volatility Regime: Current volatility is higher than historical levels, indicating increased market uncertainty.
Options Market Signals: IV rank: N/A (no options data available), put/call ratios: N/A (no options data available), and unusual activity: N/A (no options data available).
Downside Protection: Support levels include SMA 20 ($2.06) and recent low of $1.71.
Market Context & Positioning
Sector Performance: RPID is performing relatively well within the pharmaceutical sector.
Institutional Activity: Institutional interest has increased, as seen in volume trends and buying pressure at current levels.
Correlation Analysis: The stock moves more than the market (R-squared interpretation).
Relative Valuation: Position within trading range.
Key Levels & Action Items
Critical Price Levels: SMA 20 ($2.06) and recent low of $1.71 are key support levels to monitor.
Breakout/Breakdown Levels: Technical levels above SMA 50 ($1.91) or below SMA 200 ($2.91) could trigger significant moves.
Time-Sensitive Catalysts: Earnings releases, FDA approvals, product launches, and upcoming events may drive price action in the near term.
Risk Management: Stop-loss levels can be set around $1.80 to limit potential losses, and position sizing considerations should be made due to high volatility.
Please note that this analysis is based on the provided data, and actual results may vary.
Generated
News
All RPID news →
GlobeNewswire Inc.T3·9mo ago
GlobeNewswire Inc.T3·11mo ago
GlobeNewswire Inc.T3·16mo ago
GlobeNewswire Inc.T3·17mo ago
GlobeNewswire Inc.T3·23mo ago
GlobeNewswire Inc.T3·24mo ago
GlobeNewswire Inc.T3·27mo ago
Zacks Investment ResearchT3·30mo ago
GlobeNewswire Inc.T3·30mo ago
Showing 1–10 of 50
Page 1 of 5
RPID Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 1.6723
Alpha: -121.22%
Correlation: 0.2634
R-Squared: 6.9%
Stock Volatility: 80.9%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own RPID
3 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $409K | #3246 of 3716 | -16.5% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $367K | #2713 of 3138 | +67.5% | 13F | |
| Citadel Hedge fund Ken Griffin | $28K | #6122 of 6285 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
RPID Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
RPID Insider Trading (Form 4)
Latest: 2026-07-24Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | Robert G. Spignesi Jr. | PRESIDENT AND CEO | Exer (M) | +1,402 | $0.75 | $1.1K | EDGAR |
| 2026-07-24 | Richard S Kollender | Director | Exer (M) | +3,508 | $0.75 | $2.6K | EDGAR |
| 2026-06-02 | Kirk Malloy | Director | Award (A) | +12,787 | $1.95 | $25.0K | EDGAR |
| 2026-06-02 | Sean M Wirtjes | CHIEF FINANCIAL OFFICER | Award (A) | +12,787 | $1.95 | $25.0K | EDGAR |
| 2026-06-02 | Melinda Litherland Pei | Director | Award (A) | +12,787 | $1.95 | $25.0K | EDGAR |
| 2026-06-02 | Inese Lowenstein | Director | Award (A) | +12,787 | $1.95 | $25.0K | EDGAR |
| 2026-06-02 | Robert G. Spignesi Jr. | PRESIDENT AND CEO | Award (A) | +12,787 | $1.95 | $25.0K | EDGAR |
| 2026-05-26 | Dafni Bika | Director | Award (A) | +19,300 | — | EDGAR | |
| 2026-05-26 | Kirk Malloy | Director | Award (A) | +19,300 | — | EDGAR | |
| 2026-05-26 | Richard S Kollender | Director | Award (A) | +19,300 | — | EDGAR | |
| 2026-05-26 | Inese Lowenstein | Director | Award (A) | +19,300 | — | EDGAR | |
| 2026-05-26 | Melinda Litherland Pei | Director | Award (A) | +19,300 | — | EDGAR | |
| 2026-05-22 | Bain Capital Life Sciences Partners, LP | 10%+ Owner | Buy (P) | — | — | EDGAR | |
| 2026-03-12 | Sean M Wirtjes | CHIEF FINANCIAL OFFICER | Sell (S) | −7,480 | $4.32 | -$32.3K | EDGAR |
| 2026-03-12 | Robert G. Spignesi Jr. | PRESIDENT AND CEO | Sell (S) | −17,922 | $4.11 | -$73.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
RPID Insider Holdings
11 insiders · @ $0.79
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Bain Capital Life Sciences Partners, LP | 10%+ Owner | 8,434,560 | $6.62M | $0 | 1 | 2026-05-22 |
| 2 | Longitude Capital Partners II, LLC | 10%+ Owner | 4,029,245 | $3.16M | -$3.51M | 2 | 2026-02-06 |
| 3 | Richard S Kollender | Director | 1,614,835 | $1.27M | $50.1K | 10 | 2026-07-24 |
| 4 | Robert G. Spignesi Jr. | PRESIDENT AND CEO | 1,191,973 | $935.7K | -$321.6K | 25 | 2026-07-24 |
| 5 | Sean M Wirtjes | CHIEF FINANCIAL OFFICER | 568,981 | $446.7K | -$105.1K | 18 | 2026-06-02 |
| 6 | John J. Addington Wilson | CHIEF OPERATING OFFICER | 316,762 | $248.7K | -$80.1K | 14 | 2026-03-12 |
| 7 | Melinda Litherland Pei | Director | 100,687 | $79.0K | $41.4K | 9 | 2026-06-02 |
| 8 | Kirk Malloy | Director | 70,687 | $55.5K | $45.3K | 7 | 2026-06-02 |
| 9 | Inese Lowenstein | Director | 70,687 | $55.5K | $69.5K | 8 | 2026-06-02 |
| 10 | Natale S Ricciardi | Director | 29,442 | $23.1K | $0 | 6 | 2026-03-02 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
RPID Board & Officers
As of SEC filings through Jul 24, 2026Directors 7
- Melinda Litherland Pei · since Jul 14, 2021
- Natale S Ricciardi · since Jul 14, 2021
- Richard S Kollender · since Jul 14, 2021
- Robert G. Spignesi Jr. · since Jul 14, 2021
- Inese Lowenstein · since Dec 17, 2021
- Kirk Malloy · since Jul 14, 2023
- Dafni Bika · since May 22, 2025
Officers 2
- Robert G. Spignesi Jr. · President and CEO · since Jul 14, 2021
- Sean M Wirtjes · Chief Financial Officer · since Jul 14, 2021
10% owners 4
- BCIP Life Sciences Associates, LP (entity) · since Jul 14, 2021
- Bain Capital Life Sciences Fund, L.P. (entity) · since Jul 14, 2021
- Bain Capital Life Sciences Investors, LLC (entity) · since Jul 14, 2021
- Bain Capital Life Sciences Partners, LP (entity) · since Jul 14, 2021
Changes in the last 10 years (53)
| Mar 23, 2026 | The company announced the departure of John J. Addington Wilson as Chief Operating Officer in an SEC filing |
| Feb 6, 2026 | Patrick G Enright reported in an SEC filing no longer being a 10% owner |
| Feb 6, 2026 | Longitude Venture Partners II, L.P. reported in an SEC filing no longer being a 10% owner |
| Feb 6, 2026 | Longitude Prime Partners, LLC reported in an SEC filing no longer being a 10% owner |
| Feb 6, 2026 | Longitude Prime Fund, L.P. reported in an SEC filing no longer being a 10% owner |
| Feb 6, 2026 | Longitude Capital Partners II, LLC reported in an SEC filing no longer being a 10% owner |
| Feb 6, 2026 | Bakker Juliet Tammenoms reported in an SEC filing no longer being a 10% owner |
| May 22, 2025 | The company announced the departure of Jeffrey Lawrence Schwartz from the board in an SEC filing |
| May 22, 2025 | Dafni Bika became a director |
| Oct 29, 2024 | The company announced the departure of David Hirsch from the board in an SEC filing |
| Jul 14, 2023 | Kirk Malloy became a director |
| May 5, 2023 | David Hirsch no longer listed as a 10% owner in SEC filings |
| May 17, 2022 | Klm Gp LLC became a 10% owner |
| May 17, 2022 | Kennedy Lewis Management LP became a 10% owner |
| May 17, 2022 | Kennedy Lewis Investment Management LLC became a 10% owner |
| May 17, 2022 | Kennedy Lewis Investment Holdings II LLC became a 10% owner |
| May 17, 2022 | Kennedy Lewis GP III LLC became a 10% owner |
| May 17, 2022 | Kennedy Lewis GP II LLC became a 10% owner |
| May 17, 2022 | Kennedy Lewis Capital Partners Master Fund III LP became a 10% owner |
| May 17, 2022 | Kennedy Lewis Capital Partners Master Fund II LP became a 10% owner |
| May 17, 2022 | David Chene became a 10% owner |
| May 17, 2022 | Darren Richman became a 10% owner |
| Mar 23, 2022 | The company announced the departure of Alexander Schmitz from the board in an SEC filing |
| Dec 17, 2021 | Inese Lowenstein became a director |
| Oct 1, 2021 | Richard A Keys became Chief Commercial Officer |
| Jul 20, 2021 | Gurinder Grewal reported in an SEC filing no longer being a 10% owner |
| Jul 19, 2021 | Longitude Prime Partners, LLC became a 10% owner |
| Jul 19, 2021 | Longitude Prime Fund, L.P. became a 10% owner |
| Jul 14, 2021 | Victoria Vezina became Chief Human Resources Officer |
| Jul 14, 2021 | Sean M Wirtjes became Chief Financial Officer |
| Jul 14, 2021 | Robert G. Spignesi Jr. became a director |
| Jul 14, 2021 | Robert G. Spignesi Jr. became President and CEO |
| Jul 14, 2021 | Richard S Kollender became a director |
| Jul 14, 2021 | Patrick G Enright became a 10% owner |
| Jul 14, 2021 | Natale S Ricciardi became a director |
| Jul 14, 2021 | Michael Andrew Noyes became a 10% owner |
| Jul 14, 2021 | Melinda Litherland Pei became a director |
| Jul 14, 2021 | Longitude Venture Partners II, L.P. became a 10% owner |
| Jul 14, 2021 | Longitude Capital Partners II, LLC became a 10% owner |
| Jul 14, 2021 | Jonathan Paris became Senior VP and General Counsel |
| Jul 14, 2021 | John J. Addington Wilson became Chief Operating Officer |
| Jul 14, 2021 | Jeffrey Lawrence Schwartz became a director |
| Jul 14, 2021 | Jeffrey Lawrence Schwartz became a 10% owner |
| Jul 14, 2021 | Gurinder Grewal became a 10% owner |
| Jul 14, 2021 | David Hirsch became a director |
| Jul 14, 2021 | David Hirsch became a 10% owner |
| Jul 14, 2021 | Bakker Juliet Tammenoms became a 10% owner |
| Jul 14, 2021 | Bain Capital Life Sciences Partners, LP became a 10% owner |
| Jul 14, 2021 | Bain Capital Life Sciences Investors, LLC became a 10% owner |
| Jul 14, 2021 | Bain Capital Life Sciences Fund, L.P. became a 10% owner |
| Jul 14, 2021 | BCIP Life Sciences Associates, LP became a 10% owner |
| Jul 14, 2021 | Alexander Schmitz became a director |
| Jul 14, 2021 | Adam Koppel became a 10% owner |
Not reported recently (16)
- Jeffrey Lawrence Schwartz · Last reported as a 10% owner in an SEC filing dated May 28, 2024
- Victoria Vezina · Last reported as Chief Human Resources Officer in an SEC filing dated Mar 12, 2024
- Jonathan Paris · Last reported as Senior VP and General Counsel in an SEC filing dated Mar 13, 2023
- Klm Gp LLC · Last reported as a 10% owner in an SEC filing dated Jun 6, 2022
- Kennedy Lewis Management LP · Last reported as a 10% owner in an SEC filing dated Jun 6, 2022
- Kennedy Lewis Capital Partners Master Fund II LP · Last reported as a 10% owner in an SEC filing dated Jun 6, 2022
- Darren Richman · Last reported as a 10% owner in an SEC filing dated Jun 6, 2022
- Kennedy Lewis Investment Holdings II LLC · Last reported as a 10% owner in an SEC filing dated Jun 6, 2022
- Kennedy Lewis GP III LLC · Last reported as a 10% owner in an SEC filing dated Jun 6, 2022
- David Chene · Last reported as a 10% owner in an SEC filing dated Jun 6, 2022
- Kennedy Lewis Investment Management LLC · Last reported as a 10% owner in an SEC filing dated Jun 6, 2022
- Kennedy Lewis GP II LLC · Last reported as a 10% owner in an SEC filing dated Jun 6, 2022
- Kennedy Lewis Capital Partners Master Fund III LP · Last reported as a 10% owner in an SEC filing dated Jun 6, 2022
- Richard A Keys · Last reported as Chief Commercial Officer in an SEC filing dated Feb 15, 2022
- Adam Koppel · Last reported as a 10% owner in an SEC filing dated Jul 21, 2021
- Michael Andrew Noyes · Last reported as a 10% owner in an SEC filing dated Jul 14, 2021
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
RPID Proposed Insider Sales (Form 144)
Latest: 2026-07-08
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-07-08 | Wilson John J. Addington | Former Officer | 10,000 | $17.0K | 2026-07-08 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-07-01 | Wilson John J. Addington | Former Officer | 6,312 | $11.0K | 2026-07-01 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-06-22 | Wilson John J. Addington | Former Officer | 3,688 | $6.5K | 2026-06-22 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-06-10 | Wilson John J. Addington | Former Officer | 5,000 | $9.3K | 2026-06-10 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-03-11 | WIRTJES SEAN M | Officer | 7,480 | $32.3K | 2026-03-11 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-03-11 | Wilson John J. Addington | Officer | 9,603 | $41.5K | 2026-03-11 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-03-10 | Spignesi Robert G. Jr. | Officer, Director | 17,922 | $73.7K | 2026-03-10 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-02-20 | Wilson John J. Addington | Officer | 5,403 | $21.2K | 2026-02-20 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-02-20 | WIRTJES SEAN M | Officer | 17,254 | $67.7K | 2026-02-20 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-02-19 | Spignesi Robert G. Jr. | Officer, Director | 38,327 | $148.9K | 2026-02-19 | Fidelity Brokerage Services LLC | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
5 ETFs hold RPID
5 shown · $1.08M total exposure · 0.01% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $773,514 | — | 2026-09-30 |
| 2 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $208,843 | — | 2026-09-30 |
| 3 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.01% | $89,120 | $1.2B | 2026-10-23 |
| 4 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.00% | $9,023 | — | 2026-10-23 |
| 5 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.00% | $499 | — | 2026-10-23 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.